Aktis Oncology, Inc. ($AKTS)
Filing Information
| Accession Number | 0001193125-26-300163 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 10, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
150,000
Total Value
$1,570,557.78
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 50,000 | $3.66 | $183,000.00 | 50,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 8, 2026 | Sale | 15,800 | $27.13 | $428,680.86 | 34,200 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 8, 2026 | Sale | 30,000 | $27.94 | $838,137.00 | 4,200 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 8, 2026 | Sale | 4,200 | $28.75 | $120,739.92 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jul 8, 2026 | Exercise/Conversion | 50,000 | $0.00 | $0.00 | 217,888 | Direct | โ | View Details |